GISTT RACE · Research Alliance for CurE

Network

GISTT-RACE connects research institutions, affiliated sites, patient organizations and supporters around the world.

Institutions

Institutions of the scientists who have pledged to take part in GISTT-RACE: 25 institutions in 12 countries.

Essen: West German Cancer Center, University Hospital EssenMünster: University Hospital MünsterMannheim: University Medical Center Mannheim, Heidelberg UniversityOslo: Oslo University HospitalWarsaw: Maria Sklodowska-Curie National Research Institute of OncologyDublin: University College DublinLondon: The Royal MarsdenLyon: Centre Léon BérardBordeaux: Institut BergoniéMilan: Fondazione IRCCS Istituto Nazionale dei TumoriBarcelona: Vall d’Hebron Institute of Oncology (VHIO)Boston: Brigham and Women’s Hospital, Mass General Brigham, Harvard Medical School; Dana-Farber Cancer InstituteNew York: Memorial Sloan Kettering Cancer CenterPhiladelphia: Fox Chase Cancer Center; University of PennsylvaniaBethesda: National Cancer Institute, NIHMiami: Sylvester Comprehensive Cancer Center, University of MiamiHouston: MD Anderson Cancer CenterPortland: OHSU Knight Cancer InstituteLos Angeles: Cedars-Sinai Medical CenterSan Diego: UC San Diego Moores Cancer CenterSeoul: Asan Medical CenterOsaka: JCHO Osaka HospitalHangzhou: Zhejiang Sci-Tech University Essen · Münster · MannheimOsloWarsawDublinLondonLyonBordeauxMilanBarcelonaBoston 2New YorkPhiladelphia 2BethesdaMiamiHoustonPortlandLos AngelesSan DiegoSeoulOsakaHangzhou

Select a dot to see the institutions in that city. On a phone, swipe the map sideways.

Germany

  • West German Cancer Center, University Hospital Essen · Essen
  • University Medical Center Mannheim, Heidelberg University · Mannheim
  • University Hospital Münster · Münster

China

  • Zhejiang Sci-Tech University · Hangzhou

France

  • Institut Bergonié · Bordeaux
  • Centre Léon Bérard · Lyon

Ireland

  • University College Dublin · Dublin

Italy

  • Fondazione IRCCS Istituto Nazionale dei Tumori · Milan

Japan

  • JCHO Osaka Hospital · Osaka

Norway

  • Oslo University Hospital · Oslo

Poland

  • Maria Sklodowska-Curie National Research Institute of Oncology · Warsaw

South Korea

  • Asan Medical Center · Seoul

Spain

  • Vall d’Hebron Institute of Oncology (VHIO) · Barcelona

USA

  • National Cancer Institute, NIH · Bethesda
  • Brigham and Women’s Hospital, Mass General Brigham, Harvard Medical School · Boston
  • Dana-Farber Cancer Institute · Boston
  • MD Anderson Cancer Center · Houston
  • Cedars-Sinai Medical Center · Los Angeles
  • Sylvester Comprehensive Cancer Center, University of Miami · Miami
  • Memorial Sloan Kettering Cancer Center · New York
  • Fox Chase Cancer Center · Philadelphia
  • University of Pennsylvania · Philadelphia
  • OHSU Knight Cancer Institute · Portland
  • UC San Diego Moores Cancer Center · San Diego

United Kingdom

  • The Royal Marsden · London

Affiliated sites

Most people with GIST are diagnosed and treated close to home, in private practices and non-academic hospitals. Many do not know that it can be worth seeing a GIST specialist at least once, at the time of diagnosis. Affiliated sites are local partners that close this gap: each one pairs with a GISTT-RACE site, so that every new patient is discussed with GIST specialists from the start, hears about trials and reGISTTry, and travels as little as possible.

Affiliated sites also prepare the way for the GISTT-RACE platform trial. Its first-line cohorts can only succeed if patients learn about the trial when it matters: at diagnosis, before treatment begins. The aim is a community of patients with GIST who shape their treatment from the very beginning.

The affiliated site pledges

  • to pair with one GISTT-RACE site of its choice
  • to connect every patient newly diagnosed with GIST with that site at diagnosis, with the patient's consent
  • to check with that site whether an interventional clinical trial or the reGISTTry registry would be of interest to the patient
  • to discuss trial options before first-line treatment begins, where the patient's situation allows

In return

  • it is listed as a local partner of GISTT-RACE
  • it can present its patients in the tumor board of its GISTT-RACE site, at diagnosis and at any later point
  1. PledgeThe practice or hospital chooses its GISTT-RACE site and signs the affiliation.
  2. At diagnosisEach new patient with GIST is discussed with the GISTT-RACE site, including whether a trial or reGISTTry fits.
  3. Along the wayTreatment stays local wherever possible; the tumor board remains open for questions, progression and resistance.

The first affiliated sites will be listed here.

To become an affiliated site, write to info@gistt-race.org with the subject “GISTT-RACE affiliated site” and the GISTT-RACE site you would like to pair with.

Private practices and hospitals can also register online to receive trial updates and information on educational events: Join the network →

Patient support groups, advocacy and organizations

Patient organizations working with GISTT-RACE and / or supported the GISTT Summit.

Road to the Cure for GIST Cancer

Netherlands

Contactgroep GIST

GISTERS

Industry supporters

To be announced.

To join the network, please contact info@gistt-race.org.